Multimodal Prehabilitation for Lung Cancer Surgery
(MMP-LUNG Trial)
Trial Summary
Will I have to stop taking my current medications?
You may need to stop taking omega-3 supplements during the study. If you are taking vitamin D, you can continue unless your vitamin D levels are too high. The protocol does not specify other medications.
What data supports the effectiveness of the treatment Multimodal Prehabilitation for Lung Cancer Surgery?
Research shows that multimodal prehabilitation, which includes nutrition and exercise, can improve functional capacity and reduce postoperative complications in lung cancer patients. Malnourished patients, in particular, benefit significantly from this approach, showing the greatest improvements.12345
Is multimodal prehabilitation safe for humans?
In a study involving lung cancer patients, multimodal prehabilitation, which includes nutritional supplements and exercise, was generally well-tolerated with high adherence rates. However, 16% of participants reported side effects, indicating that while it is mostly safe, some individuals may experience minor issues.12367
How does the multimodal prehabilitation treatment for lung cancer surgery differ from other treatments?
Multimodal prehabilitation for lung cancer surgery is unique because it combines exercise, nutritional support, and psychological preparation before surgery to improve patients' physical condition and reduce complications. This approach is different from standard treatments that typically focus on post-surgery recovery, as it aims to enhance patients' overall health and readiness for surgery, potentially leading to better outcomes.12389
What is the purpose of this trial?
The main objective of this randomized controlled trial (RCT) is to investigate whether a multimodal prehabilitation intervention combining a mixed-nutrient supplement with structured exercise training (MM) or the supplement alone (NUT), against a placebo (CTRL), leads to improvement in functional capacity and postoperative outcomes in surgical patients with lung cancer, at nutritional risk. This will be tested in a single centre RCT of 3 parallel arms, double-blinded for the supplement. Female and male participants (n=168, \>=45 y) will be randomized to a 10-week intervention spanning 4 weeks pre-surgery and 6 weeks post-hospital discharge. The primary outcome is functional capacity as measured by the 6-minute walk test. Secondary outcomes include muscle mass, quality and strength, quality of life, length of hospital stay, and postoperative complications.
Research Team
Stéphanie Chevalier, PhD
Principal Investigator
McGill University
Eligibility Criteria
This trial is for adults over 45 with early-stage lung cancer (NSCLC stages I, II or IIIa) who are at nutritional risk and scheduled for specific types of lung surgery. They must be able to exercise and not already taking certain supplements. People with severe kidney issues, recent chemo or radiotherapy, allergies to milk/seafood, or language barriers can't join.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Prehabilitation
Participants receive a multimodal prehabilitation intervention including a mixed-nutrient supplement and structured exercise training for 4 weeks prior to surgery
Postoperative Intervention
Participants continue the intervention with a focus on recovery, including the same multimodal approach for 6 weeks after hospital discharge
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Mixed-nutrient supplement (NUT)
- Multimodal Prehabilitation (MM)
- Placebo Control (CTRL)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Stéphanie Chevalier
Lead Sponsor
Canadian Institutes of Health Research (CIHR)
Collaborator